Limited Competition: Centers of Biomedical Research Excellence (COBRE) Phase III - Transitional Centers (P30 Clinical Trial Optional)

基金名称
Limited Competition: Centers of Biomedical Research Excellence (COBRE) Phase III - Transitional Centers (P30 Clinical Trial Optional)
资助机构
U.S. Department of Health and Human Services
地区
United States
研究领域
Medicine, General Medicine
Biochemistry, Genetics and Molecular Biology, General Biochemistry,Genetics and Molecular Biology
截止日期
May 27, 2022 (已过期)
基金规模
Up to 750,000 USD
联系方式
Gao,Hongwei hongwei.gao@nih.gov
基金编号
PAR-20-115
说明
The purpose of this Funding Opportunity Announcement (FOA) is to transition the core resources and biomedical research activities of Centers of Biomedical Research Excellence (COBRE) into independence and sustainability.

基金资源

Purdue Grant Writing Lab: Introduction to Grant Writing 打开链接
University of Wisconsin Writing Center: Planning and Writing a Grant Proposal 打开链接

快速分享


将截止日期添加到日历

May 27, 2022

你有想要在此列出的基金申报机会吗?

立即提交你的基金合作意向,发送至 support@peeref.com,我们会尽快为你审核。


Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

相关基金

International Bioethics Research Training Program (D43 Clinical Trial Optional)
Health Jun 06, 2024 12:00:00 AM EDT $230,000
Australian National Aged Care Classification (AN-ACC) Transition Fund
Aged Care 30-Jun-2024 $55,440,000.00
Aged Care Services - Specialist Dementia Care Program
Aged Care 30-Jun-2024 $5,500,000.00
Northern Territory Pathways to Community Control
Indigenous Health 30-Jun-2024 $8,750,000.00
Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science for UM1 CTSA Hub Awards (RC2 Clinical Trials Not Allowed)
Health Sep 13, 2024 12:00:00 AM EDT $500,000
Enhancing Science, Technology, EnginEering, and Math Educational Diversity (ESTEEMED) Research Education Experiences (R25 Clinical Trial Not Allowed)
Health Jan 17, 2025 12:00:00 AM EST $325,000
Industrialization and Translation of Extracellular Vesicles for use in Regenerative Medicine (U43/U44 Clinical Trials Not Allowed)
Health Jun 06, 2025 12:00:00 AM EDT $295,924
Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Non-profit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not Allowed)
Health Sep 05, 2025 12:00:00 AM EDT $300,000
Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)
Health Sep 05, 2025 12:00:00 AM EDT $1,838,436
Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional)
Health Sep 05, 2025 12:00:00 AM EDT $1,838,436